Highlights bioMérieux

Equities

Market Closed - Euronext Paris Other stock markets 11:35:20 2024-06-04 am EDT			5-day change	1st Jan Change
96.05 ^EUR	-0.31%		+2.02%	-4.52%

May. 29	BioMérieux: head injury test cleared by the FDA	CF
May. 28	BioMérieux: FDA clearance for Vidas TBI test	CF

BioMérieux, Pfizer to Collaborate on Antimicrobial Resistance Initiative in Malawi	May. 23	MT
BioMérieux S.A. acquired assets from Ares Genetics GmbH.	Apr. 28	CI
BIOMÉRIEUX : Berenberg raises its target	Apr. 26	CF
BIOMÉRIEUX : Stifel raises target price	Apr. 10	CF
BIOMÉRIEUX : Oddo BHF raises its target price	Apr. 10	CF
BIOMÉRIEUX : Invest Securities raises its target	Apr. 10	CF
BIOMERIEUX : A strong start to 2024	Apr. 09
BioMérieux: hailed for its business review and targets	Apr. 09	CF
BioMérieux: targets set for 2024-28	Apr. 09	CF
BioMérieux: growth of over 6% in Q1	Apr. 09	CF
BioMérieux: food safety initiative	Apr. 05	CF
BIOMERIEUX : Good end to 2023; routine testing dynamics remain intact	Mar. 14
BioMérieux S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
BioMérieux: RNPG down 21% in 2023	Mar. 14	CF
BioMérieux Buys Remaining 84% Stake in Canada's Lumed	Jan. 08	MT
BioMérieux: full acquisition of Lumed	Jan. 08	CF
BioMérieux S.A. acquired remaining 84% stake in Luméd inc.	Jan. 04	CI
BIOMÉRIEUX : Invest Securities remains Buy after sales figures	23-10-27	CF
BioMérieux: confirms targets for fiscal 2023	23-10-26	CF
BioMerieux Partners with White Labs to Develop GENE-Up® BrewPRO? Yeast Slurry	23-10-24	CI

No results for this search

BIOMERIEUX : A strong start to 2024

April 09, 2024 at 10:38 am EDT